| JRARX | VIGAX | JRARX / VIGAX | |
| Total Expense Ratio | 1.32 | 0.05 | 2,640% |
| Annual Report Gross Expense Ratio | 1.38 | 0.05 | 2,760% |
| Fund Existence | 9 years | 25 years | - |
| Gain YTD | -3.355 | -2.986 | 112% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 3000 | 83% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 28.2B | 352B | 8% |
| Annual Yield % from dividends | 0.00 | 0.41 | - |
| Returns for 1 year | 0.05 | 14.30 | 0% |
| Returns for 3 years | 60.87 | 94.67 | 64% |
| Returns for 5 years | 26.58 | 79.49 | 33% |
| Returns for 10 years | N/A | 395.75 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ASEA | 19.61 | 0.09 | +0.46% |
| Global X FTSE Southeast Asia ETF | |||
| DFEB | 48.22 | -0.03 | -0.06% |
| FT Vest US Equity Deep Bffr ETF Feb | |||
| RSSY | 19.72 | -0.10 | -0.50% |
| Return Stacked U.S. Stocks & Futures Yield ETF | |||
| FNCL | 76.38 | -0.63 | -0.82% |
| Fidelity MSCI Financials ETF | |||
| LGHT | 9.57 | -0.27 | -2.75% |
| Langar Global HealthTech ETF | |||